Status:
TERMINATED
Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast
Lead Sponsor:
Georgetown University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue. PURPOSE: This phase I trial is studying genes and prote...
Detailed Description
OBJECTIVES: * Assess tumor gene expression information from women undergoing surgery for breast cancer or core biopsy sampling of the breast. OUTLINE: This is a pilot study. Tumor tissue is collect...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Undergoing surgery for breast cancer OR core biopsy sampling of the breast
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
September 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00898937
Start Date
September 1 1999
End Date
July 1 2017
Last Update
April 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States, 20007